Article Details
Retrieved on: 2019-01-06 03:40:07
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Benchmark Capital</b> Advisors increased its stake in Sarepta Therapeutics I Com (SRPT) by 100% based on its latest 2018Q3 regulatory filing with the ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here